January Capital Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.32M Sell
6,400
-7
-0.1% -$2.4K 1.94% 15
2026
Q1
$2.25M Buy
+6,407
New +$2.28M 3.04% 7
2022
Q2
$1.51M Hold
6,195
– – 1.34% 13
2022
Q1
$1.51M Sell
6,195
-197
-3% -$45.3K 1.34% 13
2021
Q4
$1.44M Buy
+6,392
New +$1.35M 1.14% 23

Other funds holding AMGN

January Capital Advisors's AMGN Position: Q2 2026 in Review

January Capital Advisors reduced its Amgen (AMGN) stake by 0.11% in Q2 2026, selling an estimated $2.4K and leaving 6,400 shares worth $2.32M. The position accounts for 1.94% of the portfolio, ranked #15.

January Capital Advisors first reported a position in AMGN in Q4 2021 and has held it in 5 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • January Capital Advisors held 6,400 shares of Amgen worth $2.32M as of Q2 2026.
  • January Capital Advisors sold 7 Amgen shares in Q2 2026, an estimated $2.4K.
  • Amgen made up 1.94% of January Capital Advisors's portfolio in Q2 2026, its #15 holding.
  • January Capital Advisors first reported a position in Amgen in Q4 2021 and has held it in 5 quarters since.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on January Capital Advisors's 13F filing for Q2 2026, filed 25 Aug 2026.